Does UnitedHealthcare Cover Weight Loss Treatment in Maine? A 2026 Guide

Last updated: July 19, 2026

If you have UnitedHealthcare (UHC) insurance in Maine and are exploring weight loss treatment options, understanding your plan’s coverage can make a meaningful difference in out-of-pocket costs. This guide covers what UHC commercial plans in Maine may cover for weight loss. Including GLP-1 medications, behavioral counseling, and telehealth. Along with Maine-specific pharmacy (OptumRx) formulary details, prior authorization requirements, and electronic prescribing rules.

Check if your UnitedHealthcare plan may cover weight loss treatment → Verify your benefits at Klarity Health

Key Facts: UnitedHealthcare Weight Loss Coverage in Maine (2026)

• Insurer: UnitedHealthcare (UHC)
• PBM (Pharmacy Benefit Manager): OptumRx
• Weight loss parity law: Maine’s mental health parity statute (Me. Rev. Stat. Ann. tit. 24-A, § 2749-A) applies to mental health and substance use disorder benefits only. It does not require insurers to cover weight loss medications or obesity treatment
• Federal parity: The ACA requires UHC to cover obesity screening and counseling as a preventive service, but GLP-1 weight loss medications are not federally mandated as an essential health benefit for commercial plans
• EPCS status: GLP-1s (Wegovy, Zepbound, Saxenda), Contrave, and orlistat are non-scheduled controlled substances. Maine EPCS is entirely inapplicable. Phentermine and Qsymia (Schedule IV) require electronic prescribing under Maine’s EPCS mandate
• Coverage varies: Weight loss drug coverage depends on whether your specific UHC plan includes a weight management or obesity treatment benefit rider
• Key contacts: UHC Member Services 1-800-638-0824 | OptumRx 1-855-427-4682 | Maine Bureau of Insurance 1-800-300-5000

Does UnitedHealthcare Cover Weight Loss Medications in Maine?

UHC commercial plans in Maine administered through OptumRx may cover FDA-approved weight loss medications, but coverage is not guaranteed. Whether GLP-1 medications like Wegovy or Zepbound are covered depends on two things: (1) whether your employer-sponsored or individual plan includes a weight management benefit, and (2) whether your prescriber submits documentation that meets OptumRx prior authorization criteria.

Maine’s mental health parity law (Me. Rev. Stat. Ann. tit. 24-A, § 2749-A) does not apply here. That statute governs mental health and substance use disorder benefits for commercial insured plans. Weight loss treatment sits outside its scope. Maine has not enacted a state mandate requiring commercial insurers to cover obesity medications, which means coverage is entirely plan-design dependent.

Under the Affordable Care Act, UHC must cover obesity screening and behavioral counseling (USPSTF Grade B recommendation) at no cost-sharing as a preventive service. This covers visits with a primary care provider to screen BMI and provide brief counseling. It does not extend to prescription weight loss medications.

OptumRx Weight Loss Formulary: What May Be Covered

OptumRx is UHC’s pharmacy benefit manager in Maine. The following table outlines the formulary status of common weight loss medications, their controlled substance schedule, and Maine EPCS applicability.

Formulary tiers and coverage availability vary by plan. Tiers above apply only when a weight management benefit is included in your UHC plan. Verify your specific benefit by calling OptumRx at 1-855-427-4682.

Maine EPCS Rules for Weight Loss Medications

Maine requires electronic prescribing for controlled substances (EPCS) under its pharmacy practice rules, which cover a broad range of Schedule II. V substances. This is an important consideration for patients prescribed phentermine or Qsymia in Maine.

Here is how Maine’s EPCS mandate applies to common weight loss medications:

• GLP-1 medications (Wegovy, Zepbound, Saxenda, Ozempic, Mounjaro): Not scheduled. Maine EPCS is entirely inapplicable. Prescribers may issue paper or electronic prescriptions as they prefer.
• Contrave (naltrexone/bupropion): Not scheduled. Maine EPCS inapplicable.
• Orlistat (Xenical/Alli): Not scheduled. Maine EPCS inapplicable.
• Phentermine (generic): Schedule IV controlled substance. Maine EPCS REQUIRED. Prescribers in Maine must transmit phentermine prescriptions electronically to OptumRx or a retail pharmacy.
• Qsymia (phentermine/topiramate): Schedule IV controlled substance. Maine EPCS REQUIRED. Also subject to a REMS program due to phentermine’s stimulant component and topiramate’s teratogenicity risk.

Maine vs. Hawaii vs. Federal EPCS: Weight Loss Medication Comparison

Maine’s broader EPCS mandate (Schedule II. V) means phentermine and Qsymia require electronic prescribing in Maine, while the same medications would not require EPCS under Hawaii state law or under federal DEA rules alone. This is a practical compliance point for telehealth prescribers in Maine.

Prior Authorization for Weight Loss Medications Under OptumRx

When a UHC plan does include a weight management benefit, OptumRx typically requires prior authorization (PA) for GLP-1 medications. PA criteria commonly include:

• BMI threshold: BMI ≥ 30 kg/m², or BMI ≥ 27 kg/m² with at least one weight-related comorbidity (type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea)
• Documented lifestyle intervention: Evidence of participation in a structured behavioral weight management program for 3. 6 months
• Prescriber documentation: Medical records confirming diagnosis, BMI, and comorbidities
• Step therapy (for some plans): Trial of a lower-tier agent or behavioral intervention before escalating to a GLP-1
• Ongoing use criteria: Some plans require documented weight loss of at least 5% at 12. 16 weeks to continue coverage

How to Appeal a Weight Loss PA Denial: 5 Steps

1. Request the denial in writing. UHC must provide a written explanation of the PA denial with the specific clinical criteria not met.
2. Ask your provider to submit additional documentation. BMI records, comorbidity diagnoses, and prior lifestyle counseling documentation often resolve initial denials.
3. File a Level 1 internal appeal. Call UHC Member Services at 1-800-638-0824 within 180 days of the denial. Internal appeals must be decided within 30 days (non-urgent) or 72 hours (urgent/expedited).
4. Request an external independent review. If the internal appeal is denied, Maine law requires UHC to offer an external review by an independent organization. Request this within 4 months of the final internal denial.
5. File a complaint with Maine Bureau of Insurance. If you believe UHC is improperly denying a covered benefit, contact the Maine Bureau of Insurance at 1-800-300-5000 or online at maine.gov/pfr/insurance.

What Weight Loss Parity Law Applies in Maine?

Maine’s mental health parity law. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Requires commercial insurers to cover mental health and substance use disorder treatment at parity with medical/surgical benefits. This statute does not apply to weight loss or obesity treatment.

Maine has not enacted a standalone state mandate requiring commercial plans to cover GLP-1 weight loss medications. Weight loss benefit inclusion is therefore a plan design choice made by employers (for employer-sponsored plans) or by UHC for individual market products.

For employees covered under ERISA self-funded employer plans, Maine state insurance law generally does not apply. Federal ERISA and any applicable ACA requirements govern instead.

What Weight Loss Treatments May UHC Cover in Maine?

When a UHC plan includes weight management benefits, the following types of services may be covered:

• Obesity screening and counseling (preventive): Covered at no cost-sharing under the ACA for adults with a BMI ≥ 30 when provided by an in-network primary care provider. Includes brief behavioral counseling sessions.
• Intensive behavioral therapy (IBT) for obesity: For Medicare Advantage members, CMS covers IBT for obesity. 22 visits in the first year. For commercial plans, coverage varies.
• Telehealth weight management visits: Many UHC plans cover telehealth consultations for weight management, including video visits with a prescriber licensed in Maine.
• Medical nutrition therapy (MNT): Covered for members with diabetes or renal disease. May be covered for obesity on some UHC plans with a registered dietitian.
• Prescription weight loss medications: GLP-1s, phentermine, Qsymia, Contrave, and orlistat may be covered when the plan includes a weight management benefit and PA criteria are met.
• Bariatric surgery: Covered on many UHC plans with documented BMI ≥ 40 or ≥ 35 with serious comorbidities, plus completion of a supervised weight management program. PA required.

How to Verify Your UnitedHealthcare Weight Loss Coverage in Maine: 5 Steps

1. Locate your plan documents. Log in to myuhc.com and download your Summary of Benefits and Coverage (SBC) and Evidence of Coverage (EOC). Search for “weight management,” “obesity,” and “bariatric” to understand your benefit design.
2. Call OptumRx to confirm formulary coverage. Call 1-855-427-4682 and ask whether Wegovy, Zepbound, or your prescribed medication is covered under your specific plan and at what tier. Confirm PA requirements and BMI criteria.
3. Ask your provider to run a benefit verification. Your prescriber’s office can verify coverage and submit a PA on your behalf before your prescription is sent to the pharmacy.
4. Submit a PA if required. Work with your provider to compile BMI records, comorbidity documentation, and any prior treatment history. Submit through OptumRx PA portal or by calling 1-855-427-4682.
5. Appeal any denials promptly. A denial is not always the final word. Follow the 5-step appeal process above or contact the Maine Bureau of Insurance at 1-800-300-5000 for assistance.

See if your UHC plan may cover weight loss treatment with Klarity Health. Verify your benefits today

Weight Loss Treatment at Klarity Health

Klarity Health connects patients in Maine with licensed providers who specialize in medically supervised weight loss. Our network of 2,000+ providers offers telehealth weight management consultations, including evaluation for GLP-1 medications where clinically appropriate and where coverage allows.

Our providers can help you understand your UHC benefit, run a benefits verification, and. When your plan covers weight loss treatment. Submit prior authorization on your behalf. All visits are conducted via secure video, with providers licensed in Maine.

Frequently Asked Questions

Does UnitedHealthcare cover Wegovy or Zepbound in Maine?

Coverage for Wegovy (semaglutide) and Zepbound (tirzepatide) through UHC’s OptumRx formulary depends on whether your specific plan includes a weight management benefit. When covered, these medications typically require prior authorization with documentation of BMI ≥ 30 (or ≥ 27 with comorbidities) and may require step therapy. Many standard UHC commercial plans in Maine do not include a weight loss drug benefit. Contact OptumRx at 1-855-427-4682 to verify your specific plan.

Is phentermine covered by UnitedHealthcare in Maine?

Phentermine may be covered by UHC plans that include a weight management benefit, typically at Tier 2. 3 through OptumRx. Because phentermine is a Schedule IV controlled substance, Maine EPCS rules apply. Prescribers in Maine must transmit phentermine prescriptions electronically. Prior authorization may be required depending on your plan.

Does Maine parity law require UHC to cover weight loss treatment?

No. Maine’s mental health parity law (Me. Rev. Stat. Ann. tit. 24-A, § 2749-A) covers mental health and substance use disorder treatment only. It does not require UHC or any commercial insurer in Maine to cover weight loss medications or obesity treatment programs. Coverage is determined by your plan’s benefit design.

Do GLP-1 medications require electronic prescribing in Maine?

No. GLP-1 medications. Including Wegovy, Zepbound, Ozempic, Mounjaro, and Saxenda. Are not controlled substances. Maine’s EPCS mandate (which covers Schedule II. V) does not apply to GLP-1s. Prescribers may issue these prescriptions via paper or electronic methods. Only Schedule IV medications like phentermine and Qsymia trigger Maine EPCS requirements.

Can I get a weight loss consultation via telehealth with UHC in Maine?

Many UHC plans cover telehealth consultations for weight management, including video visits with a licensed provider in Maine. The ACA preventive services requirement covers obesity screening and counseling at no cost-sharing for in-network primary care providers. For medication management visits beyond preventive counseling, telehealth coverage depends on your specific plan design. Verify with UHC Member Services at 1-800-638-0824.

What if UHC denies my weight loss medication PA in Maine?

You have the right to appeal. Submit a Level 1 internal appeal to UHC within 180 days of the denial by calling 1-800-638-0824. If the internal appeal is upheld, request an independent external review. If you believe UHC is improperly denying a covered benefit, you may also file a complaint with the Maine Bureau of Insurance at 1-800-300-5000.

Key Contacts for UHC Weight Loss Coverage in Maine

• UHC Member Services: 1-800-638-0824 (on the back of your UHC member ID card)
• OptumRx (pharmacy benefits): 1-855-427-4682
• Maine Bureau of Insurance: 1-800-300-5000 | maine.gov/pfr/insurance
• Maine DHHS: 1-800-977-6740 (MaineCare/Medicaid. Separate from UHC commercial)
• DOL EBSA (ERISA/self-funded plans): 1-866-444-3272

Coverage Disclaimer: Insurance coverage for weight loss treatment varies significantly by plan. The information in this guide reflects general OptumRx formulary practices and UHC plan structures as of July 2026, but does not constitute a guarantee of coverage. Always verify your specific benefits directly with UHC and OptumRx before beginning treatment. Coverage determinations are made by your insurer, not by Klarity Health.